"By 2020, 1.7 megabytes of data will be generated per person per second." How to navigate, filter, and analyze, when planning #clinicaltrials? Find out in a Phesi-authored article in the The Medicine Maker themedicinemaker.com/discovery-deve…

Phesi explain how predictive analytical tools can cut through the noise and select the data that will significantly impact the quality of clinical trials and result in breakthroughs for the pharmaceutical industry.

Pleased to announce that Otis Johnson has joined Phesi as Chief Commercial Officer - see today's press release for more information. Welcome Otis! businesswire.com/news/home/2019…

Using AI to Improve Clinical Development - check out this podcast interview with Phesi founder Gen Li on The Bio Report! linkedin.com/in/dslevinebio/ #AI #clinicaldevelopment #artificialintelligence

Wonder if relying on a single #clinicaltrials database source like clinicaltrials.gov is effective, or risky? See our blog for insights. Reach out for a live review of the spreadsheet we reference, with comparison to our 21st Century solution. lnkd.in/e-Eu7Ni

Our Chief Commercial Officer, Otis Johnson shares his career journey in pursuit of making #drugdevelopment more efficient as related tech has evolved, from academia and #pharma through major CROs and now at Phesi with its AI-driven platform. Read on! phesi.com/post/otis-john…

We analyzed a recent #metastaticbreastcancer #clinicaltrial and found nearly 1/3 sites recruited few patients. The drug was approved but with much extra time and higher costs. Read our latest blog for details. #breastcancer #BCAM #advancedbreastcancer bit.ly/2lF0FM4

This 2 min video shows how we help companies pinpoint the right #clinicaltrials sites and successfully develop therapies while saving significant time and money. Schedule a ClinSite demo at [email protected] #biopharma #lifesciences #AI #MachineLearning vimeo.com/369622722

We’re thrilled to announce that OncoSec Medical is using ClinSite to enable more accurate and precise planning of Phase 2 and 3 #clinicaltrials of anticancer immunotherapies. Read more in today’s press release #cancer #immunotherapy #immunooncology businesswire.com/news/home/2020…

We're thrilled to be the Industry Leader feature in the Feb. 2020 issue of @LifeSciLeader1 magazine! Phesi founder Gen Li, PhD, MBA provides tips for pharma execs to ask the right q's and avoid trial rescue situations.

Thank you Phesi for becoming a sponsor at SCOPE 2020! Be sure to visit them at booth #122. #SCOPE2020 #clinicaltrials

Excited to be returning to #SCOPE2020 next week! Come visit us at Booth #122 and try our #artificialintelligence-based ClinSite SaaS study site selection tool to identify top sites and investigators for any therapeutic area, including #rarediseases. #clinicaltrials

Honored to be featured in this prestigious magazine alongside other biopharma industry leaders! lifescienceleader.com/doc/clinical-t…

What are the updated metrics on the prevalence and causes of protocol amendments and what does this mean for us? FIND OUT by participating in the SCOPE Summit interactive breakout session co-moderated by Phesi's biz dev lead Dan Manak! #SCOPE2020 #clinicaltrials

If you’re attending SCOPE Summit don’t miss Dan Manak at TABLE 2 in the interactive breakout session tomorrow (Feb. 20) as he co-moderates “Embracing Best Practices in Protocol Design to Reduce Protocol Amendments and Improve Trials” #SCOPE2020

Plan for Friday SCOPE Summit - our founder and president Gen Li will be chairing the 8:20 AM session in Regency Ballroom U: “Improving Site Selection, Engagement and Process: Consent, EHR Platforms, Contracting & Data-Driven Course Correction” #SCOPE2020

Our biz dev lead Dan Manak co-led a SCOPE Summit roundtable where all agreed that using #DataAnalytics up front and identifying challenges "sooner than later" was one key to avoiding #clinicaltrial amendments later on. Visit us booth 122 #Scope2020

At SCOPE Summit? Come to the Fri. AM panel featuring speakers from Boehringer Ingelheim, IQVIA, AstraZeneca , Merck and Cognizant, moderated by our founder and president Gen Li #SCOPE2020

Our booth was bombarded at SCOPE Summit, filling up a lot of our time in Orlando with riveting dialogue about the need to stop talking and start doing more to improve the way #clinicaltrials are being planned and done. Read our top 5 takeaways: phesi.com/5-key-takeaway… #scope2020

Our new patent is a major game changer! Per Annalisa Jenkins, "This technology allows drug companies to expedite delivery of new treatment options to patients in need, leaving no excuse for poorly designed protocols and/or flawed operational planning.” bwnews.pr/2Q90sNm